AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-4,256 Cr | ₹-3,978 Cr | ₹-3,212 Cr | ₹599 Cr | ₹-1,568 Cr |
What is the latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-4,256 Cr |
Mar2023 | ₹-3,978 Cr |
Mar2022 | ₹-3,212 Cr |
Mar2021 | ₹599 Cr |
Mar2020 | ₹-1,568 Cr |
How is Cash Flow from Investing Activities of AUROBINDO PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-4,256 Cr | Negative | |
Mar2023 | ₹-3,978 Cr | Negative | |
Mar2022 | ₹-3,212 Cr | Negative | |
Mar2021 | ₹599 Cr | Positive | |
Mar2020 | ₹-1,568 Cr | - |
Compare Cash Flow from Investing Activities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,667.3 Cr | -4.2% | -7.8% | -12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -4.2% |
-7.8% |
-12.7% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses